← Weight Loss
Coming soon — join the waitlist Branded

Wegovy® pill, the oral GLP-1: coming soon to Gala.

Oral semaglutide, FDA-approved for weight reduction on December 22, 2025. One tablet a day, no needles. Join the waitlist and we'll email you when Gala can prescribe it.

Wegovy® pill
FromPricing at launch

Coming soon. Join the waitlist.

  • Provider visit included
  • Free shipping
  • Cancel anytime
FSA & HSA accepted
  • Oral once-daily semaglutide
  • FDA-approved for weight reduction (December 2025)
  • Join the waitlist — first to access at launch
Compare options
Wegovy® pill
0%Average loss on oral semaglutide 25 mg at 64 weeks, OASIS 4
0 mgDaily maintenance dose, reached on day 91 of the label schedule
0 minWait after the tablet before food, drink or other pills
How it works

Same molecule, no needle

Wegovy tablets contain semaglutide, the same GLP-1 molecule as the Wegovy injection, combined with an absorption enhancer so it can be absorbed from the stomach. That is also why the label's empty-stomach rules matter: food and drink cut absorption.

The data

A daily pill, a familiar curve.

The curve illustrates the general shape of GLP-1 weight loss against diet alone; it is not a Wegovy tablet result. The OASIS 4 numbers are in the next section.

0−10 lbs−20 lbs−30 lbsStartMo 1Mo 2Mo 3Mo 4Mo 5Mo 6
Outcomes

OASIS 4: oral semaglutide 25 mg vs placebo

Oral semaglutide 25 mg
−13.6%
Placebo
−2.2%

Average body-weight change at 64 weeks in OASIS 4 (Wharton et al., NEJM 2025). Digestive side effects were reported by 74.0% on semaglutide vs 42.2% on placebo.

What to expect

Your first six months on Wegovy® pill.

This is the Wegovy tablet schedule from the FDA label: one tablet a day, with the strength rising every 30 days.

Days 1–30

1.5 mg daily

The starting strength, to let your body adjust.

Days 31–60

4 mg daily

First step up. If a dose is not tolerated, the label says to consider delaying escalation.

Days 61–90

9 mg daily

Second step up.

Day 91+

25 mg daily

The maintenance dose on the label.

Is it right for you

Wegovy® pill works best for…

  • Strongly prefer oral medication over injections
  • Have needle phobia or injection-site sensitivity
  • Can take a tablet on an empty stomach every morning
How to start

From assessment to treatment in a week.

1

Take the assessment

Quick health questionnaire — about 5 minutes. We use it to match you to the right medication and dose.

2

Provider review

A US-licensed clinician reviews your full profile and either prescribes or comes back with a question.

3

Medication ships

Your medication arrives free of charge with everything you need to start. Provider support is included.

FDA approval and what it covers

The FDA approved Wegovy tablets on December 22, 2025. They share the Wegovy label with the injection: with a reduced-calorie diet and more physical activity, to reduce excess body weight and keep it off in adults with obesity or overweight plus a weight-related condition, and to lower the risk of major heart events in adults with established heart disease. Strengths are 1.5, 4, 9 and 25 mg.

How to take the Wegovy® pill

  • Once a day in the morning, on an empty stomach.
  • With up to 4 ounces of plain water, and no other liquid.
  • Swallow it whole; do not split, crush or chew it.
  • Wait at least 30 minutes before eating, drinking or taking other oral medicines.

Side effects in OASIS 4

Digestive side effects were common: 74.0% of people on oral semaglutide 25 mg reported one vs 42.2% on placebo. The label's gradual 30-day steps are there to reduce them. Do not take more than one tablet a day; if you miss a dose, the label says to skip it and take the next one the following day.

Pill or injection?

They were studied in separate trials, so the numbers should not be compared head to head: oral semaglutide 25 mg averaged 13.6% loss at 64 weeks in OASIS 4, and the Wegovy 2.4 mg injection averaged 14.9% at 68 weeks in STEP 1. The pill trades a weekly shot for a daily routine with strict timing. Both carry the same boxed warning about thyroid C-cell tumors.

Gala does not prescribe the Wegovy pill yet. Until it does, a Gala provider can review you for compounded semaglutide, compounded tirzepatide or Ozempic.

Frequently asked questions

Is the Wegovy® pill FDA-approved?

Yes. The FDA approved Wegovy tablets on December 22, 2025, for weight reduction and heart risk reduction in eligible adults, alongside the Wegovy injection.

When will it be available through Gala?

Gala does not prescribe the Wegovy pill yet. Join the waitlist and we'll email you the moment it's available through Gala.

How does it compare to injectable semaglutide?

Same molecule, different trials. Oral semaglutide 25 mg was studied in OASIS 4 at 64 weeks and the Wegovy injection in STEP 1 at 68 weeks, so the results should not be compared directly. The pill must be taken daily on an empty stomach; the injection is weekly. Wegovy pill vs injection

What are the Wegovy® pill doses?

The label starts at 1.5 mg daily for 30 days, then 4 mg for 30 days, then 9 mg for 30 days, then the 25 mg daily maintenance dose from day 91.

What are the Wegovy® pill side effects?

Digestive effects such as nausea, vomiting, diarrhea and constipation are the most common, as with the injection. The label carries a boxed warning about thyroid C-cell tumors.

Be first to access Wegovy® pill.

Join the waitlist and we'll email you the moment it's available.